The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Hyperleptinemia as a Component of a Metabolic Syndrome of Cardiovascular Risk
Open accessAbstract
Abstract —In humans, production of the adipocyte-derived peptide leptin has been linked to adiposity, insulin, and insulin sensitivity. We therefore considered that alterations in plasma leptin concentrations could constitute an additional component of a metabolic syndrome of cardiovascular risk. To explore this hypothesis, we employed factor analysis, a multivariate statistical technique that allows reduction of large numbers of highly intercorrelated variables to composite, biologically meaningful factors. Seventy-four men [age, 48.4±1.3 years (mean±SEM); body mass index (BMI), 25.6±0.3 kg/m 2 ] who were free of coronary heart disease and diabetes underwent anthropometric measurements (subscapular-to-triceps [S:T] and subscapular-to-biceps [S:B] skinfold thickness ratios, measurement of fasting plasma leptin, and an intravenous glucose tolerance test (IVGTT) for assessment of insulin sensitivity. Plasma leptin concentrations were correlated with BMI ( r =0.57, P <0.001), S:T ( r =0.34, P =0.003), S:B ( r =0.37, P <0.001), systolic and diastolic blood pressures (both r =0.24, P =0.044), fasting triglycerides ( r =0.31, P =0.007), serum uric acid ( r =0.35, P =0.003), fasting glucose ( r =0.32, P =0.003) and insulin ( r =0.33, P =0.004), and IVGTT insulin ( r =0.63, P <0.001). A negative correlation was observed between leptin and insulin sensitivity ( r =−0.32, P =0.006). No significant correlations emerged between plasma leptin concentrations and age, high density lipoprotein cholesterol, or IVGTT glucose. In multivariate regression analyses, BMI (standardized coefficient [SC] =0.40, P =0.001), fasting insulin (SC=0.23, P =0.036), and IVGTT insulin (SC=0.51, P <0.001) emerged as independent predictors of plasma leptin concentrations ( R 2 =0.56, P <0.001). After adjustment for BMI, only IVGTT insulin emerged as a significant predictor of plasma leptin concentrations (SC=0.56, P <0.001, R 2 =0.45, P <0.001). Factor analysis of plasma leptin concentrations and the variables that are considered relevant to the insulin resistance syndrome revealed a clustering of plasma leptin concentrations with a factor dominated by insulin resistance and high IVGTT insulin, separate from a high IVGTT glucose/central obesity factor and a high triglyceride/low high density lipoprotein cholesterol factor. Together, these factors accounted for 55.9% of the total variance in the dataset. In conclusion, interindividual variations in plasma leptin concentrations are strongly related to the principal components of the insulin resistance syndrome. Further studies are needed to determine whether the insulin-leptin axis plays a coordinating role in this syndrome and whether plasma leptin concentrations could provide an additional measure of cardiovascular risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Applied Multivariate Statistics for the Social Sciences
Stevens, J. P. (2012) · Routledge eBooks · doi:10.4324/9780203843130 · Cited by 10,648
Durnin, J. V. G. A., & Womersley, J. (1974) · British Journal of Nutrition · doi:10.1079/bjn19740060 · Cited by 6,343
Serum Immunoreactive-Leptin Concentrations in Normal-Weight and Obese Humans
Considine, R. V., Sinha, M. K., Heiman, M. L., Kriauciunas, A., Stephens, T. W., Nyce, M. R., Ohannesian, J. P., Marco, C. C., McKee, L. J., Bauer, T. L., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602013340503 · Cited by 6,326
Quantitative Determination of Serum Triglycerides by the Use of Enzymes
Bucolo, G., & David, H. (1973) · Clinical Chemistry · doi:10.1093/clinchem/19.5.476 · Cited by 3,188
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874
Frederich, R. C., Hamann, A., Anderson, S., Löllmann, B., Lowell, B. B., & Flier, J. S. (1995) · Nature Medicine · doi:10.1038/nm1295-1311 · Cited by 1,660
Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen
Trinder, P. (1969) · Journal of Clinical Pathology · doi:10.1136/jcp.22.2.158 · Cited by 1,656
Warnick, G. R., & Albers, J. J. (1978) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41577-9 · Cited by 1,250
Transient increase in obese gene expression after food intake or insulin administration
Saladin, R., De Vos, P., Guerre-Millot, M., Leturque, A., Girard, J., Staels, B., & Auwerx, J. (1995) · Nature · doi:10.1038/377527a0 · Cited by 1,093
Siedel, J., Hägele, E. O., Ziegenhorn, J., & Wahlefeld, A. W. (1983) · Clinical Chemistry · doi:10.1093/clinchem/29.6.1075 · Cited by 942
Nocturnal rise of leptin in lean, obese, and non-insulin-dependent diabetes mellitus subjects.
Sinha, M. K., Ohannesian, J. P., Heiman, M. L., Kriauciunas, A., Stephens, T. W., Magosin, S., Marco, C., & Caro, J. F. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118551 · Cited by 784
Insulin Sensitivity and Atherosclerosis
Howard, G., O’Leary, D. H., Zaccaro, D., Haffner, S., Rewers, M., Hamman, R., Selby, J. V., Saad, M. F., Savage, P., & Bergman, R. (1996) · Circulation · doi:10.1161/01.cir.93.10.1809 · Cited by 729
Overexpression of the obese (ob) gene in adipose tissue of human obese subjects
Lönnqvist, F., Arner, P., Nordfors, L., & Schalling, M. (1995) · Nature Medicine · doi:10.1038/nm0995-950 · Cited by 706
Acute and Chronic Effect of Insulin on Leptin Production in Humans: Studies In Vivo and In Vitro
Kolaczynski, J. W., Nyce, M. R., Considine, R. V., Boden, G., Nolan, J. J., Henry, R., Mudaliar, S. R., Olefsky, J., & Caro, J. F. (1996) · Diabetes · doi:10.2337/diab.45.5.699 · Cited by 700
Albano, J. D. M., Ekins, R. P., Maritz, G., & Turner, R. C. (1972) · Acta Endocrinologica · doi:10.1530/acta.0.0700487 · Cited by 620
Increased obese mRNA expression in omental fat cells from massively obese humans
Hamilton, B. S., Paglia, D., Kwan, A. Y. M., & Deitel, M. (1995) · Nature Medicine · doi:10.1038/nm0995-953 · Cited by 526
Sexual Dimorphism in Plasma Leptin Concentration
Saad, M. F. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.2.579 · Cited by 501
Relationship Between Insulin Sensitivity and Plasma Leptin Concentration in Lean and Obese Men
Segal, K. R., Landt, M., & Klein, S. (1996) · Diabetes · doi:10.2337/diab.45.7.988 · Cited by 493
Insulin and Cortisol Promote Leptin Production in Cultured Human Fat Cells
Wabitsch, M., Bo Jensen, P., Blum, W. F., Christoffersen, C. T., Englaro, P., Heinze, E., Rascher, W., Teller, W., Tornqvist, H., & Hauner, H. (1996) · Diabetes · doi:10.2337/diab.45.10.1435 · Cited by 472
Plasma Leptin and Insulin Relationships in Obese and Nonobese Humans
Dagogo-Jack, S., Fanelli, C., Paramore, D., Brothers, J., & Landt, M. (1996) · Diabetes · doi:10.2337/diab.45.5.695 · Cited by 396
De Vos, P., Lefebvre, A. M., Miller, S. G., Guerre-Millo, M., Wong, K., Saladin, R., Hamann, L. G., Staels, B., Briggs, M. R., & Auwerx, J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118860 · Cited by 357
Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes.
Kallen, C. B., & Lazar, M. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5793 · Cited by 337
The ob Gene and Insulin: A Relationship Leading to Clues to the Understanding of Obesity
Cusin, I., Sainsbury, A., Doyle, P., Rohner-Jeanrenaud, F., & Jeanrenaud, B. (1995) · Diabetes · doi:10.2337/diab.44.12.1467 · Cited by 276
Insulin increases plasma leptin concentrations in normal subjects and patients with NIDDM
Malmström, R., Taskinen, M. R., Karonen, S. L., & Yki-JÄrvinen, H. (1996) · Diabetologia · doi:10.1007/bf00403921 · Cited by 247
Hollenberg, A. N., Susulic, V. S., Madura, J. P., Zhang, B., Moller, D. E., Tontonoz, P., Sarraf, P., Spiegelman, B. M., & Lowell, B. B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.8.5283 · Cited by 247
UKPDS 20: Plasma Leptin, Obesity, and Plasma Insulin in Type 2 Diabetic Subjects
Widjaja, A., STRATTON, I. M., Horn, R., Holman, R. R., Turner, R. C., & Brabant, G. E. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.2.654 · Cited by 177
Zhang, B., Graziano, M. P., Doebber, T. W., Leibowitz, M. D., White-Carrington, S., Szalkowski, D. M., Hey, P. J., Wu, M., Cullinan, C. A., Bailey, P., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.16.9455 · Cited by 173
Multivariate analysis of the insulin resistance syndrome in women.
Edwards, K. L., Austin, M. A., Newman, B., Mayer, E., Krauss, R. M., & Selby, J. V. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.12.1940 · Cited by 160
Ryan, A. S., & Elahi, D. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.12.8954055 · Cited by 129
Effect of Troglitazone on Leptin Production: Studies In Vitro and in Human Subjects
Nolan, J. J., Olefsky, J. M., Nyce, M. R., Considine, R. V., & Caro, J. F. (1996) · Diabetes · doi:10.2337/diab.45.9.1276 · Cited by 113
Leptin concentrations and insulin sensitivity in normoglycemic men
Haffner, S., Miettinen, H., Mykkänen, L., et al. (1997) · International Journal of Obesity · doi:10.1038/sj.ijo.0800419 · Cited by 97
Declaring independence: why we should be cautious.
Smith, G. D., & Phillips, A. N. (1990) · Journal of Epidemiology & Community Health · doi:10.1136/jech.44.4.257 · Cited by 90
Godsland, I. F., Crook, D., Walton, C., Wynn, V., & Oliver, M. F. (1992) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.12.9.1030 · Cited by 52
Self-citation
Cited by
Components of the “Metabolic Syndrome” and Incidence of Type 2 Diabetes
Hanson, R. L., Imperatore, G., Bennett, P. H., & Knowler, W. C. (2002) · Diabetes · doi:10.2337/diabetes.51.10.3120 · Cited by 590
Human Leptin Enhances Activation and Proliferation of Human Circulating T Lymphocytes
Martín-Romero, C., Santos-Alvarez, J., Goberna, R., & Sánchez-Margalet, V. (2000) · Cellular Immunology · doi:10.1006/cimm.1999.1594 · Cited by 524
Obesity, adipocytokines, and insulin resistance in breast cancer
Rose, D. P., Komninou, D., & Stephenson, G. D. (2004) · Obesity Reviews · doi:10.1111/j.1467-789x.2004.00142.x · Cited by 460
Sakkinen, P. A., Wahl, P., Cushman, M., Lewis, M. R., & Tracy, R. P. (2000) · American Journal of Epidemiology · doi:10.1093/aje/152.10.897 · Cited by 420
Meigs, J. B. (2000) · American Journal of Epidemiology · doi:10.1093/aje/152.10.908 · Cited by 401
Metadata
- Authors
- Leyva, F., Godsland, I. F., Ghatei, M., Proudler, A. J., Aldis, S., Walton, C., Bloom, S., & Stevenson, J. C.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 1998-06
- Volume
- 18
- Issue
- 6
- Pages
- 928-933
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2074152129
- Cited by
- 253
- References
- 35
- FWCI
- 12.25
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.